1. Home
  2. FEMY vs CRT Comparison

FEMY vs CRT Comparison

Compare FEMY & CRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Femasys Inc.

FEMY

Femasys Inc.

HOLD

Current Price

$0.82

Market Cap

51.5M

Sector

Health Care

ML Signal

HOLD

Logo Cross Timbers Royalty Trust

CRT

Cross Timbers Royalty Trust

HOLD

Current Price

$7.88

Market Cap

42.5M

Sector

Energy

ML Signal

HOLD

Company Overview

Basic Information
Metric
FEMY
CRT
Founded
2004
1991
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Oil & Gas Production
Sector
Health Care
Energy
Exchange
Nasdaq
Nasdaq
Market Cap
51.5M
42.5M
IPO Year
2021
1992

Fundamental Metrics

Financial Performance
Metric
FEMY
CRT
Price
$0.82
$7.88
Analyst Decision
Strong Buy
Analyst Count
3
0
Target Price
$6.83
N/A
AVG Volume (30 Days)
1.4M
25.4K
Earning Date
11-14-2025
03-12-2026
Dividend Yield
N/A
9.36%
EPS Growth
N/A
N/A
EPS
N/A
0.74
Revenue
$2,061,502.00
$5,621,913.00
Revenue This Year
$64.02
N/A
Revenue Next Year
$147.19
N/A
P/E Ratio
N/A
$10.68
Revenue Growth
63.53
N/A
52 Week Low
$0.31
$7.07
52 Week High
$1.80
$13.31

Technical Indicators

Market Signals
Indicator
FEMY
CRT
Relative Strength Index (RSI) 47.72 44.57
Support Level $0.79 $7.34
Resistance Level $0.89 $8.27
Average True Range (ATR) 0.07 0.31
MACD -0.01 -0.06
Stochastic Oscillator 26.39 37.72

Price Performance

Historical Comparison
FEMY
CRT

About FEMY Femasys Inc.

Femasys Inc is a biomedical company focused on transforming women's healthcare by developing solutions and advancements providing clinical impact to address severely underserved areas. The company's mission is to provide women with minimally invasive, non-surgical product technologies, accessible in the office, improving patient care and overall health economics. Its product portfolio includes FemaSeed Intratubal Insemination, an infertility treatment; FemVue, a companion diagnostic for fallopian tube assessment via ultrasound; FemBloc, a clinical product candidate being developed as a permanent birth control; FemCerv, a tissue sampler for cervical cancer diagnosis; and FemCath and FemChec. Geographically, it derives key revenue from the United States and rest from international markets.

About CRT Cross Timbers Royalty Trust

Cross Timbers Royalty Trust is a United States-based trust. The net profits interests are derived from producing royalty, overriding royalty interests, and working interest properties. The underlying properties of the trust include producing properties in Texas, Oklahoma, and New Mexico.

Share on Social Networks: